Sharad A Ghamande

Department Chair

Obstetrics and Gynecology

Phone706/721-3992
Emailsghamande@augusta.edu

839 Citations
15 h-Index

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Ovarian Neoplasms Medicine & Life Sciences

Platinum Medicine & Life Sciences

Paclitaxel Medicine & Life Sciences

Uterine Cervical Neoplasms Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Carboplatin Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

Safety Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

839 Citations
15 h-Index
33 Article
2 Letter

1 Citation (Scopus)

A combined score of clinical factors and serum proteins can predict time to recurrence in high grade serous ovarian cancer

Mysona, D., Pyrzak, A., Purohit, S. B., Zhi, W., Sharma, A. K., Tran, L., Tran, P., Bai, S., Rungruang, B. J., Ghamande, S. A. & She, J-X., Mar 1 2019, In : Gynecologic Oncology. 152, 3, p. 574-580 7 p.

Research output: Contribution to journal › Article

Ovarian Neoplasms

Blood Proteins

Recurrence

Disease-Free Survival

Proteins

7 Citations (Scopus)

Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

Falchook, G., Coleman, R. L., Roszak, A., Behbakht, K., Matulonis, U., Ray-Coquard, I., Sawrycki, P., Duska, L. R., Tew, W., Ghamande, S. A., Lesoin, A., Schwartz, P. E., Buscema, J., Fabbro, M., Lortholary, A., Goff, B., Kurzrock, R., Martin, L. P., Gray, H. J., Fu, S. & 6 others, Sheldon-Waniga, E., Lin, H. M., Venkatakrishnan, K., Zhou, X., Leonard, E. J. & Schilder, R. J., Jan 2019, In : JAMA Oncology. 5, 1

Research output: Contribution to journal › Article

Paclitaxel

Ovarian Neoplasms

Randomized Controlled Trials

Breast Neoplasms

Disease-Free Survival

Bovine Pericardial Graft for Second-Trimester Cesarean Scar Dehiscence

Stephens, A., Patel, K., Davis, J. & Ghamande, S., Feb 1 2019, In : Obstetrics and Gynecology. 133, 2, p. 364-367 4 p.

Research output: Contribution to journal › Article

Second Pregnancy Trimester

Cicatrix

Transplants

Pregnancy

Premature Obstetric Labor

2 Citations (Scopus)

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

Research output: Contribution to journal › Article

Carboplatin

Paclitaxel

Ovarian Neoplasms

Placebos

Disease-Free Survival

16 Citations (Scopus)

A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In : Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

Research output: Contribution to journal › Article

Carboplatin

Platinum

Ovarian Neoplasms

Pharmacokinetics

Clinical Trials